From July 1, 2023 to July 13, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 14,523,100 shares, representing 2.57% for CNY 79.72 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.47 CNY | +5.67% | -6.09% | -27.08% |
1st Jan change | Capi. | |
---|---|---|
-27.08% | 344M | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.